The U.S. Food and Drug Administration has approved Pfizer’s Geodon as an add-on treatment for bipolar disorder. The drug, which is already approved for use in schizophrenia and BPD, can also be used as an adjunct to lithium or valproate.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2010. The HealthCentral Network, Inc. All rights reserved.
